Dr. Kevin P. Rosenblatt is a renowned physician, scientist, and innovator in molecular medicine with expertise in clinical proteomics and genomic diagnostics. He has held academic appointments at prestigious institutions and has made significant contributions to the field of proteomics and systems biology. Dr. Rosenblatt has also been involved in commercial and non-academic appointments, serving as Chief Medical Officer and Chief Scientific Officer of several companies. He is the Director of Healix Pathology, a laboratory specializing in blood test analysis for traumatic brain injury (TBI) testing. 

Orthobiologics Network and Healix Pathology Labs may not be official partners in a traditional sense, but they work together synergistically to help as many victims of traumatic brain injury (TBI) as possible. Orthobiologics Network specializes in providing cutting-edge orthobiologic treatments for TBI patients, while Healix Pathology Labs, under the leadership of Dr. Kevin P. Rosenblatt, conducts blood test analysis for TBI testing. The accurate and timely diagnostic results provided by Healix Pathology Labs are crucial in guiding the appropriate orthobiologic treatments offered by Orthobiologics Network. In this sense, they collaborate closely to ensure TBI patients receive comprehensive and effective care. Their shared mission to improve outcomes for TBI patients makes them partners in the broader sense of working towards a common goal of helping those affected by traumatic brain injury.

Dr. Rosenblatt’s educational background is impressive, with a Ph.D. from the University of Texas Southwestern Graduate School for the Biomedical Sciences in Neuroscience, and an M.D. from the University of Texas Southwestern Medical School at Dallas. He has completed fellowships in Translational Pathology and Tissue Proteomics at the National Cancer Institute/National Institutes of Health, further solidifying his expertise in molecular medicine and diagnostics.

Throughout his career, Dr. Rosenblatt has been recognized for his contributions to the field of molecular medicine and has received numerous awards and honors. He is widely published in prestigious scientific journals and is a sought-after speaker and consultant in the field of proteomics, genomics, and molecular diagnostics.

He is dedicated to advancing the field of molecular medicine and improving patient care through the development and implementation of innovative diagnostic technologies. Dr. Rosenblatt’s unwavering commitment to excellence and his passion for advancing the field of molecular medicine make him a respected and esteemed figure in the medical and scientific communities.